Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →

NATIONAL BRAIN TUMOR SOCIETY ON BEHALF OF DEADLIEST CANCERS COALITION

Organization · MA
Hires government relations

Support for brain tumor patients, caregivers, researchers, and other medial providers

Who they hire

2026 · 3 filings · Budget/Appropriations, Health Issues, Medicare/Medicaid
$██,███ / qtrFree in beta

What they lobby on

Report language on deadliest cancers in the FY 2027 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2027 LHHSAppropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2027 Defense Appropriations bill
Budget/Appropriations · 2026 Q2
Support for the Clinical Trials Modernization Act (S. 4440/H.R. 3521)
Health Issues · 2026 Q2
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Medicare/Medicaid · 2026 Q1
Report language on deadliest cancers in the FY 2026 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2026 LHHSAppropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2026 Defense Appropriations bill Report language on deadliest cancers in the FY 2027 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2027 LHHSAppropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2027 Defense Appropriations bill
Budget/Appropriations · 2026 Q1
Advocating on behalf of the deadliest cancers, which are defined by the Recalcitrant Cancer Research Act as those with a five-year relative survival rate below 50 percent.
Budget/Appropriations · 2026 Q3